Marcel A M Beijk

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi request reprint XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent
    Marcel A M Beijk
    Academic Medical Center, University of Amsterdam, Department of Cardiology, Meibergdreef 9, PO Box 22660, 1105 AZ Amsterdam, The Netherlands
    Expert Rev Med Devices 4:11-21. 2007
  2. doi request reprint Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study
    Marcel A M Beijk
    Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 78:189-95. 2011
  3. doi request reprint One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent
    Marcel A M Beijk
    Department of Cardiology, Academic Medical Center University of Amsterdam, Amsterdam, The Netherlands
    Atherosclerosis 213:525-31. 2010
  4. doi request reprint Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry
    Margo Klomp
    Department of Cardiology, Cardiac Catheterization Laboratory, B2 137 Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Heart Vessels 27:360-9. 2012
  5. doi request reprint Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis
    Pier Woudstra
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 81:26-33. 2013
  6. ncbi request reprint Long-term follow-up after nonurgent percutaneous coronary intervention in unprotected left main coronary arteries
    Marcel A M Beijk
    Department of Cardiology, University of Amsterdam, Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 75:1026-36. 2010
  7. doi request reprint One-year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent
    Margo Klomp
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 77:809-17. 2011
  8. pmc Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study
    Marcel A M Beijk
    Department of Cardiology, Academic Medical Center, University of Amsterdam, B2 137 Meibergdreef 9, PO Box 22660, 1105 AZ Amsterdam, The Netherlands
    Eur Heart J 31:1055-64. 2010
  9. doi request reprint Clinical outcomes after percutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction: a single-centre experience
    Maik J Grundeken
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Heart 99:690-9. 2013
  10. doi request reprint Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent
    Margo Klomp
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
    J Interv Cardiol 24:442-9. 2011

Collaborators

Detail Information

Publications17

  1. ncbi request reprint XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent
    Marcel A M Beijk
    Academic Medical Center, University of Amsterdam, Department of Cardiology, Meibergdreef 9, PO Box 22660, 1105 AZ Amsterdam, The Netherlands
    Expert Rev Med Devices 4:11-21. 2007
    ..an Abbott Vascular Company, CA, USA) may provide enhanced deliverability, radiopacity with thinner strut filaments and, owing to a durable polymer, sustained drug elution and vascular compatibility...
  2. doi request reprint Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study
    Marcel A M Beijk
    Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 78:189-95. 2011
    ..At 1 yr, a statistically nonsignificant difference in the rates of target vessel failure (cardiac death, myocardial infarction, or target vessel revascularization) was observed. We have evaluated the safety and efficacy up to 2 yr...
  3. doi request reprint One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent
    Marcel A M Beijk
    Department of Cardiology, Academic Medical Center University of Amsterdam, Amsterdam, The Netherlands
    Atherosclerosis 213:525-31. 2010
    ....
  4. doi request reprint Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry
    Margo Klomp
    Department of Cardiology, Cardiac Catheterization Laboratory, B2 137 Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Heart Vessels 27:360-9. 2012
    ..Furthermore, the presence of diabetes mellitus did not influence the incidence of TVF in either risk group...
  5. doi request reprint Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis
    Pier Woudstra
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 81:26-33. 2013
    ..To evaluate the clinical results of diabetic patients undergoing percutaneous coronary intervention (PCI) for coronary artery lesions carrying a low risk of restenosis treated with a bare-metal stent (BMS)...
  6. ncbi request reprint Long-term follow-up after nonurgent percutaneous coronary intervention in unprotected left main coronary arteries
    Marcel A M Beijk
    Department of Cardiology, University of Amsterdam, Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 75:1026-36. 2010
    ....
  7. doi request reprint One-year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent
    Margo Klomp
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Catheter Cardiovasc Interv 77:809-17. 2011
    ....
  8. pmc Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study
    Marcel A M Beijk
    Department of Cardiology, Academic Medical Center, University of Amsterdam, B2 137 Meibergdreef 9, PO Box 22660, 1105 AZ Amsterdam, The Netherlands
    Eur Heart J 31:1055-64. 2010
    ..The purpose of this study was to evaluate the Genous(TM) endothelial progenitor cell capturing stent vs. the Taxus Liberté paclitaxel-eluting stent in patients with de novo coronary lesions with a high-risk of coronary restenosis...
  9. doi request reprint Clinical outcomes after percutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction: a single-centre experience
    Maik J Grundeken
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Heart 99:690-9. 2013
    ..We evaluated 30-day and 1-year clinical outcomes after percutaneous or surgical coronary revascularisation in patients with unprotected left main coronary artery (ULMCA)-related acute myocardial infarction (AMI)...
  10. doi request reprint Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent
    Margo Klomp
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
    J Interv Cardiol 24:442-9. 2011
    ....
  11. doi request reprint A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria
    Marcel A M Beijk
    Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Coron Artery Dis 22:32-9. 2011
    ..We performed a retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention (PCI) comparing bare metal stent (BMS) with drug-eluting stent (DES) using the NICE guidelines...
  12. doi request reprint Differences in cardiovascular risk factors and clinical outcomes between Western European and Southeast Asian patients treated with the Genous Bio-engineered R stent: an e-HEALING worldwide registry substudy
    Margo Klomp
    Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
    Coron Artery Dis 23:271-7. 2012
    ..In our current analysis, we evaluate the differences in baseline clinical, angiographic and procedural characteristics, and 12-month clinical outcomes in patients undergoing nonurgent PCI in Western Europe and in Asia...
  13. doi request reprint Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention
    Marcel A M Beijk
    Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
    Pharmacogenet Genomics 20:544-52. 2010
    ....
  14. doi request reprint Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction
    Peter Damman
    Department of Cardiology, Academic Medical Center University of Amsterdam, Amsterdam, The Netherlands
    J Am Coll Cardiol 57:29-36. 2011
    ..We investigated whether multiple biomarkers improve prognostication in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention...
  15. doi request reprint Design and rationale of the TRI-stent adjudication study (TRIAS) program
    Margo Klomp
    Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands
    Am Heart J 158:527-532.e1. 2009
    ....
  16. ncbi request reprint Genous endothelial progenitor cell-capturing stent system: a novel stent technology
    Margo Klomp
    Academic Medical Center, University of Amsterdam, Department of Cardiology, B2 137, Meibergdreef 9, PO Box 22660, 1105 AZ, Amsterdam, The Netherlands
    Expert Rev Med Devices 6:365-75. 2009
    ..At present, the larger randomized Tri-stent Adjudication Study (TRIAS) that is ongoing will directly compare the clinical usefulness of this new endothelial progenitor cell-capturing stent with bare-metal stents and drug-eluting stents...
  17. doi request reprint p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity
    Claudia M Van Tiel
    Department of Medical Biochemistry, University of Amsterdam, The Netherlands
    Circulation 120:669-76. 2009
    ..We therefore hypothesized that common genetic variations or single nucleotide polymorphisms in p27(kip1) may serve as a useful tool in risk stratification for in-stent restenosis...